RGEN — Repligen Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Repligen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	717	604	624	751	757
Net Total Accounts Receivable
Net Total Receivables	71.4	117	116	124	134
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	902	932	998	1,111	1,066
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	92	227	316	323	333
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,903	2,358	2,525	2,831	2,830
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	319	375	404	165	127
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	374	608	614	866	857
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,529	1,750	1,911	1,965	1,973
Total Liabilities & Shareholders' Equity	1,903	2,358	2,525	2,831	2,830
Total Common Shares Outstanding